Published

Mechanisms of therapeutic change after psychedelic treatment in OCD.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychiatry research
Date: 2024-06-01
Source: PubMed
DOI: 10.1016/j.psychres.2024.115907
PubMed: 38615521

Authors

Maloney G Ching T Kichuk SA Pittenger C Kelmendi B

Watch author

Derived topics and classifications

psilocybin OCD Mechanism of Action Emotional Processing Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01 Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model.ACS chemical neuroscience · 2026-01-21 Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.ACS pharmacology & translational science · 2026-03-13 [Psychedelics and pyschodelic-associated psychotherapies - Who is PAP for after all?].Psychiatria Hungarica: A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata · 2025-01-01 Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01 Psilocybin decelerates cellular senescenceResearch Square · 2023-06-27 Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal ObstaclesSSRN Electronic Journal · 2017-11-02 Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18